Phonak Brings EON Hearing Aid Portfolio to Veterans and Active-Duty Military

STÄFA, SWITZERLAND — Phonak has announced that its EON hearing aid portfolio is now available through the U.S. Department of Veterans Affairs (VA) and Department of Defense (DOD), expanding access to the company’s latest hearing technology for eligible veterans and active-duty military personnel....

Continue reading at Hearing Health Matters

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change to clinical practice; audiologists working within VA or DoD systems should note EON devices are now procurement-eligible, but this announcement carries no new clinical guidance.

✦ Why It Matters ✦

VA and DoD represent one of the largest single hearing-care distribution channels in the U.S., so Phonak's EON approval significantly expands the device's reach to a population with disproportionately high rates of noise-induced hearing loss.

✦ Key Points ✦

01Phonak's EON hearing aid portfolio is now available through the U.S. VA and DoD.
02Eligible veterans and active-duty military personnel can access EON devices via government benefits.
03The VA/DoD channel is among the highest-volume hearing aid procurement pathways in the U.S.
04No clinical trial data or comparative effectiveness evidence is presented in the announcement.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Phonak EON hearing aids are now available through the U.S. Department of Veterans Affairs and Department of Defense.

press releasesupported

✦ Related stories ✦

PubMed·Clinical trial·Hearing aids·2mo ago

Unilateral and Bilateral Hearing Aids for Age-Related Hearing Loss: A Randomized Clinical Trial

of this RCT directly bear on bilateral vs. unilateral fitting decisions for adults with symmetrical mild-to-moderate age-related hearing loss; full-text review is essential, but this is potentially practice-changing depending on the direction and magnitude of the findings.

PubMed·Journal article·Hearing aids·2mo ago

Hearing aids for mild to moderate hearing loss in adults

Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.

PubMed·Journal article·Hearing aids·3mo ago

Digital Interventions for First-Time Hearing Aid Users: A Systematic Review and Meta-Analysis of Efficacy and Effectiveness

Clinicians should consider incorporating evidence-based digital support tools (apps, online programmes) into onboarding protocols for first-time hearing aid users, pending the meta-analysis's specific effect-size findings.

PubMed·Journal article·Hearing aids·6w ago

Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The meta-analytic findings on self-fitting vs. professional-fitting outcomes should prompt audiologists to review their value proposition and counsel patients on where professional fitting adds measurable benefit, particularly for complex hearing profiles.

PubMed·Journal article·Hearing aids·5mo ago

Individuals with near-normal audiograms but perceived hearing difficulties can achieve aided outcomes on par with those of peers with mild hearing loss

Audiologists should consider fitting hearing aids for patients with near-normal audiograms who report significant hearing difficulty, as aided outcomes can match those of patients with confirmed mild hearing loss.

PubMed·Journal article·Hearing aids·4mo ago

The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias

If the study shows hearing-aid use reduces Alzheimer's-related plasma biomarkers, it would strengthen the case for early hearing rehabilitation as a potential dementia-prevention strategy, though findings should be weighed by sample size and study design before changing practice.

PubMed·Journal article·Hearing aids·6mo ago

Hearing Aid Efficacy-Timely Trial Finds Professional Guidance Trumps Costly Tech

This trial supports prioritising high-quality audiological fitting and counselling over premium hearing aid technology alone — audiologists should emphasise their professional value proposition when discussing device options with patients.